Open Access Open Access  Restricted Access Subscription Access

Exploratory Activity in Rats with Scopolamine Model of Cognitive Dysfunction Treated with Cholinesterase Inhibitors


Affiliations
1 Department of Pharmacology and Clinical Pharmacology, Medical University Plovdiv, Bulgaria
 

The aim was to study the effects of rivastigmine and metrifonate on the exploratory activity of rats with scopolamine model of cognitive dysfunction in "Activity cage" apparatus with photosensors (Ugo Basile, Italy). The scopolamine group with cognitive dysfunction decreased horizontal and vertical locomotor activity. Rivastigmine in a small dose can improve only the horizontal activity. Metrifonate, irrespective of the dose applied, improves the horizontal and vertical exploratory activity in rats in a significantly higher degree.

Keywords

Cholinesterase Inhibitors, Scopolamine Model, Rats, Exploratory Activity, Activity Cage.
User
Notifications
Font Size

Abstract Views: 201

PDF Views: 98




  • Exploratory Activity in Rats with Scopolamine Model of Cognitive Dysfunction Treated with Cholinesterase Inhibitors

Abstract Views: 201  |  PDF Views: 98

Authors

Darinka Slavcheva Dimitrova
Department of Pharmacology and Clinical Pharmacology, Medical University Plovdiv, Bulgaria
Damianka Peteva Getova
Department of Pharmacology and Clinical Pharmacology, Medical University Plovdiv, Bulgaria

Abstract


The aim was to study the effects of rivastigmine and metrifonate on the exploratory activity of rats with scopolamine model of cognitive dysfunction in "Activity cage" apparatus with photosensors (Ugo Basile, Italy). The scopolamine group with cognitive dysfunction decreased horizontal and vertical locomotor activity. Rivastigmine in a small dose can improve only the horizontal activity. Metrifonate, irrespective of the dose applied, improves the horizontal and vertical exploratory activity in rats in a significantly higher degree.

Keywords


Cholinesterase Inhibitors, Scopolamine Model, Rats, Exploratory Activity, Activity Cage.